v3.26.1
Stock-based Compensation - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 14, 2025
Mar. 13, 2025
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Jun. 30, 2025
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Aggregate inducement awards outstanding     3,613,410      
Number of options, outstanding     6,195,400      
Common stock, shares outstanding     104,044,508   98,776,265  
Weighted average exercise price, issued     $ 17.12      
Stock-based compensation expense recognized     $ 7,132 $ 3,426    
Nominal amount of expense in relation to ESPP recognized     276 186    
Accrued expenses     24,514   $ 20,446  
Unrecognized stock-based compensation expense related to unvested options granted     $ 23,200      
Weighted average period for recognition of unvested options granted     3 years 1 month 6 days      
Employee Stock [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Weighted average period for recognition of unvested options granted     3 years 2 months 12 days      
RSUs            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Number of other than options, outstanding     60,000      
Number of shares, granted     2,909,010      
Number of shares, vested     169,306      
Stock-based compensation expense recognized     $ 4,600 1,800    
Unrecognized stock-based compensation expense related to unvested options granted     $ 68,700      
Directors' Deferred Share Unit Plan            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Number of shares, vested     197,932      
Stock-based compensation expense recognized     $ 1,000      
Accrued expenses     $ 3,600      
Employee Stock Option            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Number of options, outstanding     3,234,410      
Number of shares, granted     307,610      
Stock-based compensation expense recognized     $ 2,400 $ 1,600    
Nominal amount of expense in relation to ESPP recognized     $ 100      
Nominal amount of expense in relation to ESPP     33,787      
Performance shares units            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Vesting percentage     200.00%      
Number of other than options, outstanding     319,000      
Number of shares, granted     34,500      
Vesting period     36 months      
Requisite service period     36 months      
Performance shares units | Tranche One            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Number of shares, granted     319,500      
Performance shares units | Tranche Two            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Number of shares, granted     639,000      
MindMed Stock Option Plan            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Vesting percentage   15.00% 15.00%      
Number of shares, granted 0          
Vesting rights, description     Prior to March 14, 2025, the Company was authorized to issue a number of equity awards equal to 15% of the Company’s issued and outstanding Common Shares under the terms of the 2020 Option Plan, together with Common Shares that were issuable pursuant to outstanding awards or grants under any other compensation or incentive mechanism involving the issuance or potential issuance of Common Shares, including the MindMed Performance and Restricted Share Unit Plan (“2020 PRSU Plan”) and ESPP.      
MindMed Stock Option Plan | Maximum            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Common stock, shares outstanding           9,318,090
MindMed Stock Option Plan | Restricted Share Unit Awards and Performance Share Unit Awards            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Common stock, shares outstanding           5,817,111
MindMed Stock Option Plan | Employee Stock Option            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Common stock, shares outstanding           3,500,979
2025 Equity Incentive Plan            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Common shares reserved for future issuance           4,500,000
2025 Equity Incentive Plan | RSUs            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Number of shares, granted     2,270,010      
2025 Equity Incentive Plan | Employee Stock Option            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Number of shares, granted     425,935      
2025 Equity Incentive Plan | Performance shares units            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Number of shares, granted     285,000      
PRSU Plan            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Vesting percentage     15.00%      
Number of shares, granted 0